
Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Vial marked 'Polonium 210' sparks scare during German Easter egg hunt - 2
When a sperm whale gives birth, the mother gets help from her friends - 3
Triumph's 400 Range Has Just Changed In India, And Here's Why - 4
Most loved Caf\u00e9 Chain: Where Do You Get Your Caffeine Fix - 5
The Delight of Perusing: Book Proposals for Each Class
At least 490 protesters killed in Iran, activists say
Vice President Dick Cheney’s life followed the arc of the biggest breakthroughs in cardiovascular medicine
Russia Fields New Ulan-2 All-Terrain Tactical Vehicle
PA accuses Israel of 'human trafficking' after planeload of Gazans arrives in South Africa
Venezuelans in Madrid celebrate Maduro's capture
Top Pastry: What's Your Sweet Treat of Decision?
Russian drone slams into block of flats in deadly wave of strikes across Kyiv
Orcas seen hunting great white sharks to eat their livers in drone footage recorded in Mexico
The EU Is Considering Lifting Tariffs on Chinese Electric Vehicles













